Related Experiment Video
Updated: Sep 20, 2026

Application of Dixon's Up-and-Down Design to Estimate the Minimum Alveolar Concentration of Sevoflurane in Rats with Refined Movement Classification
Published on: July 25, 2025
[Effect of sevoflurane on the neuromuscular blockade produced by continuous mivacurium infusion ]
J Barrio1, I Asensio, I Molina
1Servicio de Anestesiología y Reanimación, Hospital Arnau de Vilanova, Valencia. jabama16@hotmail.com
Objective:
To evaluate the effect of sevoflurane on a neuromuscular block from mivacurium in continuous infusion.
Patients And Methods:
Fourteen ASA I-II patients receiving general anesthesia for orthopedic procedures on the knee. The neuromuscular block was monitored by acceleromyography in the adductor pollicis muscle after stimulation of the cubital nerve. Anaesthesia was induced with propofol and remifentanil. After orotracheal intubation, mivacurium was given in continuous infusion adjusted to obtain a stable submaximal block defined as a variation in the block of 3% more or less for 10 minutes (first response on a train of four [T1] between 40% and 60% of the calibrated value). Values for T1, the T4/T1 ratio (TR) and temperature over the thenar eminence were recorded at 3 moments: control moment (infusion of mivacurium and sevoflurane at an expired fraction of 1.5% for 30 minutes) and post-sevoflurane moment (perfusion of mivacurium and sevoflurane at an expired fraction of 0% for 15 minutes). Statistical analysis was by analysis of variance and post-hoc contrast (Tukey).
Results:
Results are expressed as means with standard error between parentheses. We found that values at T1(%) and TR(%) were significantly lower at the sevoflurane moments (T1 = 43.11 [1]; TR = 25.68 [1]) and the post-sevoflurane moment (T1 = 36.29 [2]; TR = 25.06 [2]) than at the control moment (T1 = 53.18 [1]; TR = 38.93 [1]) (P < .05). T1 was significantly lower at the post-sevoflurane moment than at the sevoflurane moment (P < .05) but TR did not differ significantly.
Conclusion:
Sevoflurane causes a significant increase in the neuromuscular block maintained by mivacurium in continuous infusion and the increase lasts at least 15 minutes after the halogenated agent is cleared from blood.
Insights
Sevoflurane significantly intensifies neuromuscular blockade when administered with mivacurium infusions. This potentiation effect persists for at least 15 minutes after sevoflurane is no longer present in the blood.
Area of Science:
- Anesthesiology
- Pharmacology
- Neuromuscular blockade
Background:
- Mivacurium is a short-acting neuromuscular blocking agent used in anesthesia.
- Sevoflurane is a common volatile anesthetic agent.
- Understanding drug interactions is crucial for patient safety during surgery.
Purpose of the Study:
- To investigate the impact of sevoflurane on mivacurium-induced neuromuscular blockade.
- To quantify the changes in neuromuscular function during and after sevoflurane administration.
Main Methods:
- Fourteen patients undergoing orthopedic surgery received anesthesia with propofol and remifentanil.
- Neuromuscular blockade was monitored using acceleromyography of the adductor pollicis muscle.
- Mivacurium was administered via continuous infusion to maintain a stable submaximal block (T1 between 40-60%).
Main Results:
- Sevoflurane administration led to a significant decrease in the train-of-four ratio (T4/T1) and the first response (T1).
- Neuromuscular blockade was significantly deeper during sevoflurane administration compared to baseline.
- The enhanced neuromuscular blockade persisted for at least 15 minutes after sevoflurane discontinuation.
Conclusions:
- Sevoflurane significantly potentiates the neuromuscular blocking effects of mivacurium.
- The potentiation effect is sustained even after the elimination of sevoflurane from the body.
- Clinical implications include the need for careful titration of neuromuscular blocking agents when used concurrently with sevoflurane.
More Related Videos
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
04:30Stimulated Single Fiber Electromyography (SFEMG) for Assessing Neuromuscular Junction Transmission in Rodent Models
Published on: March 8, 2024
Related Concept Videos
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because succinylcholine...
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...
Skeletal Muscle Relaxants: Therapeutic Uses
Depolarizing Blockers: Pharmocokinetics